C. Kobler, F. Effenberger / Tetrahedron: Asymmetry 15 (2004) 3731–3742
3741
Conversion and isomeric ratio were directly determined
from the filtrate by gas chromatography.
Br, 22.69;O, 18.17. Found: C, 51.16;H, 4.14;N 3.83;
Br, 22.53.
4.6. General procedure for the preparation of the
p-bromobenzoylated derivatives 2a0, 5a0, and 5b0
4.6.4. cis-(1R,2S)-1-(4-Bromobenzoyloxy)-2-cyanocyclo-
pentanecarboxylic acid ethyl ester cis-(1R,2S)-
5b0. Reaction time: 14d at room temperature, Rf =
To a solution of 2a, 5a, or 5b (10.70, 1.77, or 2.84mmol,
diastereomeric ratio given in Tables 3 and 6 in 1:1 pyr-
idine/CH2Cl2 (20–80mL) was added dimethylaminopyr-
idine (ca. 0.2equiv) and p-bromobenzoyl chloride
(2.0equiv), and the reaction mixture stirred for the time
given. Water (20–50mL) was then added, the layers sep-
arated, and the aqueous layer extracted with diethyl
ether (3 · 50mL). The combined extracts were washed
with diluted HCl until neutral and then dried over
Na2SO4 and concentrated. The residue was chromato-
graphed on silica gel with petroleum ether–ethyl acetate
(50:1 for 2a0, 5:1 for 5a0, and 7:1 for 5b0) and
recrystallized.
0.21, yield: 56% cis-5b0, mp 93ꢁC (diisopropyl ether),
20
½a ¼ À1:9 (c 1.0, CHCl3). 1H NMR (500MHz): d
D
3
1.23 (t, J = 7.1Hz, 3H, CH2CH3), 1.87–2.01 (m, 2H,
2CH), 2.13–2.20 (m, 1H, CH), 2.30–2.38 (m, 1H, CH),
2.52–2.67 (m, 2H, 2 CH), 3.44 (t, 3J = 8.9Hz, 1H,
C1Hax), 4.19–4.25 (m, 2H, CH2CH3), 7.59–7.83 (m,
4H, HPh). 13C NMR (125.8MHz): d 14.21 (CH2CH3),
21.76 (C4H2), 25.81 (C5H2), 38.38 (C3H2), 54.19 (C1H),
61.64 (CH2CH3), 77.11 (C2), 117.75 (CN), 127.51,
129.42, 131.32, 132.16 (CPh), 163.40 (OCO), 169.08
(COOEt). Anal. Calcd for C16H16NO4Br (366.21): C,
52.48;H, 4.40;N, 3.82;Br, 21.82;O, 17.48. Found: C,
52.52;H, 4.49;N 3.76;Br, 21.73.
4.6.1. cis-(1S,2R)-1-(4-Bromobenzoyloxy)-2-methylcyclo-
pentanecarbonitrile cis-(1S,2R)-2a0. Reaction time: 14d
Acknowledgements
at room temperature, Rf = 0.05, yield: 33% cis-2a0, mp
20
73ꢁC (diisopropyl ether), ½a ¼ þ0:5 (c 1.0, CHCl3).
This work was supported by the Fonds der Chemischen
Industrie and the Degussa AG. The authors thank Dr.
Wolfgang Frey for X-ray crystallographic analysis,
and Dr. Angelika Baro for the help with preparing the
manuscript.
D
3
1H NMR (500MHz): d 1.29 (d, J = 6.8Hz, 3H, CH3),
1.59–1.67 (m, 1H, CH), 1.78–1.90 (m, 2H, 2CH), 2.05–
2.12 (m, 1H, CH), 2.43–2.56 (m, 3H, CH), 7.60–7.87
(m, 4H, HPh). 13C NMR (125.8MHz): d 13.06 (CH3),
21.42 (C4H2), 31.01 (C3H2), 37.40 (C5H2), 46.01 (C2H),
78.79 (C1), 118.80 (CN), 128.22, 129.01, 131.15, 132.03
(CPh), 163.90 (OCO). Anal. Calcd for C14H14NO2Br
(308.17): C, 54.56;H, 4.58;N, 4.55;Br, 25.93;O,
10.38. Found: C, 54.56;H, 4.56;N 4.56;Br, 25.89.
References
1. Enzyme-catalyzed reactions, Part 50. Part 49: Kobler, C.;
Bohrer, A.;Effenberger, F. Tetrahedron, 2004, 60, 10397–
10410.
4.6.2.
trans-(1S,2S)-1-(4-Bromobenzoyloxy)-2-methyl-
cyclopentanecarbonitrile trans-(1S,2S)-2a0. Reactions
conditions and workup see cis-(1S,2R)-2a0, Rf = 0.09,
2. Fischer, R.;Kru ger, B.-W.;Santel, H.-J.;Dollinger, M.;
¨
Wachendorff-Neumann, U.;Erdelen, C. (Bayer, A. G.),
Ger. Offen. DE 4337853, 1995; Chem. Abstr. 1995, 123,
32947p.
yield: 35% trans-2a0, mp 76ꢁC (diisopropyl ether),
20
½a ¼ þ2:6 (c 1.0, CHCl3). 1H NMR (500MHz): d
D
3. (a) Effenberger, F.;Roos, J.;Kobler, C. Angew. Chem.,
Int. Ed. 2002, 41, 1876–1879;(b) Effenberger, F.;Roos, J.;
3
1.32 (d, J = 7.0Hz, 3H, CH3), 1.48–1.67 (m, 1H, CH),
1.81–1.97 (m, 1H, CH), 2.02–2.09 (m, 1H, CH), 2.20–
2.26 (m, 1H, CH), 2.49–2.56 (m, 1H, CH), 2.67–2.73
(m, 1H, CH), 7.60–7.88 (m, 4H, HPh). 13C NMR
(125.8MHz): d 16.29 (CH3), 21.35 (C4H2), 30.49
(C3H2), 37.49 (C5H2), 44.13 (C2H), 81.93 (C1), 117.29
(CN), 127.94, 128.99, 131.25, 131.95 (CPh), 164.16
(OCO). Anal. Calcd for C14H14NO2Br (308.17): C,
54.56;H, 4.58;N, 4.55;Br, 25.93;O, 10.38. Found: C,
54.63;H, 4.61;N 4.51;Br, 25.67.
Kobler, C.;Bu hler, H. Can. J. Chem. 2002, 80, 671–679.
¨
4. (a) Skinner, W. A.;Fuhrmann, F.;Rutledge, L. C.;
Moussa, M. A.;Schreck, C. E. J. Pharm. Sci. 1980, 69,
196–198;(b) Shapiro, S. L.;Rose, I. M.;Roskin, E.;
Freedman, L. J. Am. Chem. Soc. 1956, 81, 386–390.
5. Grella, M. P.;Danso-Danquah, R.;Safo, M. K.;Joshi, G.
S.;Kister, J.;Marden, M.;Hoffman, S. J.;Abraham, D. J.
J. Med. Chem. 2000, 43, 4726–4737.
6. Miethe, P.;Kula, M. R.;Stuertz, I.;Wandrey, C. Patent
DE 4008412 C1, 1991.
7. Poechlauer, P.;Skranc, W.;Mayrhofer, H.;Wirth, I.;
Neuhofer, R.;Griengl, H.;Fechter, M. U.S. Patent
01297212 A1, 2003.
8. Smitskamp-Wilms, E.;Brussee, J.;van der Gen, A. Recl.
Trav. Chim. Pays-Bas 1991, 110, 209–215.
9. Buhler, H.;Effenberger, F.;Fo ¨rster, S.;Roos, J.;Wajant,
¨
4.6.3. cis-(1R,2S)-1-(4-Bromobenzoyloxy)-2-cyanocyclo-
pentanecarboxylic acid methyl ester cis-(1R,2S)-
5a0. Reaction time: 8h under reflux, Rf = 0.25, yield:
20
61% cis-5a0, mp 108ꢁC (ethanol), ½a ¼ À9:1 (c 1.0,
D
CHCl3). 1H NMR (500MHz): d 1.86–2.02 (m, 2H,
2CH), 2.14–2.21 (m, 1H, CH), 2.31–2.39 (m, 1H, CH),
2.53–2.66 (m, 2H, 2CH), 3.45 (t, 3J = 8.94Hz, 1H,
C1Hax), 3.76 (s, 3H, CH3), 7.60–7.81 (m, 4H, HPh).
13C NMR (125.8MHz): d 21.80 (C4H2), 25.90 (C5H2),
38.43 (C3H2), 52.55 (C1H), 54.08 (COOCH3), 76.89
(C2), 117.69 (CN), 127.45, 129.36, 131.23, 132.11
(CPh), 163.33 (OCO), 169.53 (COOCH3). Anal. Calcd
for C15H14NO4Br (352.18): C, 51.16;H, 4.01;N, 3.98;
H. Chem. Biochem. 2003, 4, 211–216.
10. (a) Effenberger, F. Angew. Chem., Int. Ed. Engl. 1994, 33,
1555–1564;(b) Fo ¨rster, S.;Roos, J.;Effenberger, F.;
Wajant, H.;Sprauer, A. Angew. Chem., Int. Ed. Engl.
1996, 35, 437–439.
11. (a) Lauble, H.;Fo¨rster, S.;Miehlich, B.;Wajant, H.;
Effenberger, F. Acta Crystallogr. Sec. D 2001, 57, 194–200;
(b) Lauble, H.;Miehlich, B.;Fo ¨rster, S.;Wajant, H.;
Effenberger, F. Protein Sci. 2001, 10, 1015–1022.